Megan Thompson
Family · New Albany, MSNPI 1851992549
Payments from drug & device makers
Across 74 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$191
- AstraZeneca$146
- Lilly USA, LLC$117
- Amgen$103
- Novo Nordisk$79
- Sumitomo Pharma America, Inc.$78
- plus $576 from 16 others
What the payments were for
- Food & beverage$1,289100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $191 |
| AstraZeneca | 8 | $146 |
| Lilly USA, LLC | 7 | $117 |
| Amgen | 7 | $103 |
| Novo Nordisk | 5 | $79 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Boehringer Ingelheim | 3 | $52 |
| Esperion Therapeutics, Inc. | 3 | $51 |
| Sanofi Pasteur Inc. | 2 | $49 |
| Genentech USA, Inc. | 3 | $37 |
| Ironwood Pharmaceuticals, Inc | 2 | $36 |
| GSK | 2 | $36 |
| VBI Vaccine (delaware) Inc. | 2 | $28 |
| Boston Scientific | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Alvogen Inc | 1 | $21 |
| Tris Pharma Inc | 1 | $19 |
| Merck | 1 | $19 |
| Medtronic | 1 | $19 |
| Antares Pharma, Inc. | 1 | $16 |
How this compares
$1,289 in reported general payments places this provider in the 70th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 60 | $143,552 |
| MounjaroTirzepatide | 42 | $100,106 |
| EliquisApixaban | 52 | $88,280 |
| FarxigaDapagliflozin Propanediol | 46 | $72,478 |
| JardianceEmpagliflozin | 35 | $55,569 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $41,423 |
| XareltoRivaroxaban | 22 | $34,312 |
| KerendiaFinerenone | 15 | $26,987 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $15,691 |
| Novolog FlexpenInsulin Aspart | 11 | $5,119 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $584 |
| Rosuvastatin Calcium | 31 | $456 |
| Gabapentin | 35 | $387 |
| Losartan Potassium | 24 | $325 |
| Pantoprazole Sodium | 11 | $247 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $79 | $143,55260 claims |
| Lilly USA, LLCMounjaro | $117 | $100,10642 claims |
| AstraZenecaFarxiga | $146 | $72,47846 claims |
| Boehringer IngelheimJardiance | $52 | $55,56935 claims |
| GSKTrelegy Ellipta | $36 | $41,42323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,007 family providers in Mississippi.
Other family in New Albany
- Kimberly HardinNew Albany$14K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.